Search
Phenacaine
go.drugbank.com/drugs/DB21274ExperimentalThe usage of the INN stem '-caine' in the name indicates that Phenacaine is a local anaesthetic. Phenacaine has a monoisotopic molecular weight of 298.17 Da.
Uldazepam
go.drugbank.com/drugs/DB21290ExperimentalThe usage of the INN stem '-azepam' in the name indicates that Uldazepam is a diazepam derivative. Uldazepam has a monoisotopic molecular weight of 359.06 Da.
Fluradoline
go.drugbank.com/drugs/DB21333ExperimentalThe usage of the INN stem '-adol/-adol-' in the name indicates that Fluradoline is a analgesic. Fluradoline has a monoisotopic molecular weight of 301.09 Da.
Pinoxepin
go.drugbank.com/drugs/DB21397ExperimentalThe usage of the INN stem '-oxepin' in the name indicates that Pinoxepin is a tricyclic compound. Pinoxepin has a monoisotopic molecular weight of 398.18 Da.
Ruzadolane
go.drugbank.com/drugs/DB21444ExperimentalThe usage of the INN stem '-adol/-adol-' in the name indicates that Ruzadolane is a analgesic. Ruzadolane has a monoisotopic molecular weight of 375.13 Da.
Timtraxanib
go.drugbank.com/drugs/DB21515ExperimentalThe usage of the INN stem '-anib' in the name indicates that Timtraxanib is a angiogenesis inhibitor. Timtraxanib has a monoisotopic molecular weight of 621.31 Da.
Synonyms: N-ac-arg-leu-tyr-gluRosabulin
go.drugbank.com/drugs/DB20161InvestigationalRosabulin has a monoisotopic molecular weight of 400.1 Da. … Rosabulin is under investigation in clinical trial NCT00276913 (A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors).
Tanogitran
go.drugbank.com/drugs/DB21367InvestigationalTanogitran has a monoisotopic molecular weight of 477.25 Da. … Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects).
Crelosidenib
go.drugbank.com/drugs/DB21642InvestigationalCrelosidenib has a monoisotopic molecular weight of 504.28 Da. … Crelosidenib is under investigation in clinical trial NCT04603001 (Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations).
Dihydroergocristine
go.drugbank.com/drugs/DB13345Approved[L2637] It is a semisynthetic ergot alkaloid and thus, it is characterized by a structural skeleton formed by an alkaloid ergoline.